Mefloquine Hydrochloride (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Mefloquine Hydrochloride drug offered from Teva Pharmaceuticals USA, Inc.. This Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Mefloquine Hydrochloride |
SUBSTANCE NAME: | MEFLOQUINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimalarial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-01-06 |
END MARKETING DATE: | 0000-00-00 |
Mefloquine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Mefloquine Hydrochloride from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2004-01-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0555-0171_1314fc15-b451-490f-beba-dbae19bba51b |
PRODUCT NDC: | 0555-0171 |
APPLICATION NUMBER: | ANDA076392 |
Other MEFLOQUINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: